Home NDC 82079-001-30 Clear Day
Product NDC 82079-001
Requested package NDC 82079-001-30
11-digit product format 820790001
Labeler code 82079
Product ID 82079-001_6d7da3e8-297c-404b-a04d-9718bbd6f58f
Type HUMAN OTC DRUG
Nonproprietary name Avobenzone, Octisalate, Octocrylene, and Homosalate
Dosage form GEL
Route TOPICAL
Labeler Soon Skin Care, Inc.
Application part352
Marketing category OTC MONOGRAPH NOT FINAL
Marketing start 2021-05-06
Marketing end 0000-00-00
Substance AVOBENZONE; OCTISALATE; OCTOCRYLENE; HOMOSALATE
Active strength 1 mg/30mL; mg/30mL; mg/30mL; mg/30mL
NDC exclude flag No
Listing certified through 2022-12-31
Current FDA listing Historical FDA.report record Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 15 matching rows.
View current auxiliary records. · View the auxiliary file history.
Captured / source date, Snapshot, Source SHA-256 table Captured / source date Snapshot Source SHA-256 2025-12-14 17:58 UTC · source 2025-12-05 d630ba8d3edf…732f749b63fb…2025-08-27 00:01 UTC · source 2025-08-26 f5e01cc5f278…a2eaf40c39c3…2025-04-01 02:39 UTC · source 2025-03-31 2ef7874e63bc…57b86245f4fa…2025-03-28 20:22 UTC · source 2025-03-28 a1b67e2a42f9…c4cf2c586c0d…2025-03-22 03:12 UTC · source 2025-03-21 cfe11265f3b6…090c488252e2…2025-03-10 12:48 UTC · source 2025-03-10 cdf11ea48f46…ba0047e9e063…2025-02-02 03:52 UTC · source 2025-01-31 302b2466d912…e7b80fea0513…2025-01-20 13:05 UTC · source 2025-01-20 ed331223b511…672a5bd82f5f…2025-01-11 03:41 UTC · source 2025-01-10 0efc9e666f02…f202fb6c5f17…2024-11-09 02:27 UTC · source 2024-11-08 ad56d346431e…cc804d4bbf1e…2024-10-04 04:10 UTC · source 2024-10-03 367a005e9d99…383a685ebd0f…2024-07-10 04:00 UTC · source 2024-07-09 557ba5c1ecfa…9c80585c8c6e…2024-05-28 21:12 UTC · source 2024-05-28 8af77b9d5b6f…d9bbb34c5368…2024-05-15 03:39 UTC · source 2024-05-14 834df4deac94…adcc014656a3…2024-03-11 06:39 UTC · source 2024-03-08 1332a3947898…d4bfe170f9cd…
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
FDA-Initiated Inactive NDC Indexing# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 82079-001-30 Clear Day Soon Sun 30 mL in 1 BOTTLE, PLASTIC GEL 30 1 82079-001-30 Clear Day Soon Sun 1 in 1 BOX GEL 1 1 82079-001-60 Clear Day Soon Sun 60 mL in 1 BOTTLE, PLASTIC GEL 60 1 82079-001-60 Clear Day Soon Sun 1 in 1 BOX GEL 1 1
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 82079-001 CLEAR DAY SOON SUN (AVOBENZONE, OCTISALATE, OCTOCRYLENE, AND HOMOSALATE) GEL [SOON SKIN CARE, INC.] 1 Legacy NDC, 4 package rows 20210831_96bc5c4c-3bba-477e-b5f3-0342cebd4ca3.zip
Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Marketing start Marketing end Sample Exclude flag Status 82079-001-30 82079000130 1 BOTTLE, PLASTIC in 1 BOX (82079-001-30) > 30 mL in 1 BOTTLE, PLASTIC 2021-05-06 0000-00-00 No No Current